Chemoinformaics analysis of 6-HEPTADECENYLSALICYLIC-ACID
| Molecular Weight | 205.169 | nRot | 1 |
| Heavy Atom Molecular Weight | 198.113 | nRig | 13 |
| Exact Molecular Weight | 205.038 | nRing | 2 |
| Solubility: LogS | -2.857 | nHRing | 1 |
| Solubility: LogP | 0.812 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 25.6756 |
| nHD | 3 | BPOL | 9.32845 |
| QED | 0.646 |
| Synth | 2.2 |
| Natural Product Likeliness | 0.492 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.065 |
| CACO-2 | -5.266 |
| MDCK | 0.00000438 |
| BBB | 0.208 |
| PPB | 0.428819 |
| VDSS | 0.56 |
| FU | 0.509705 |
| CYP1A2-inh | 0.111 |
| CYP1A2-sub | 0.103 |
| CYP2c19-inh | 0.051 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.272 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.039 |
| CL | 3.34 |
| T12 | 0.913 |
| hERG | 0.02 |
| Ames | 0.012 |
| ROA | 0.283 |
| SkinSen | 0.28 |
| Carcinogencity | 0.03 |
| EI | 0.922 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.801435 |